You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Les traitements par chimiothérapie et autres traitements systémiques pourraient être modifiés en raison de la COVID-19. Vous trouverez de plus amples renseignements à la page Traitements systémiques pendant la pandémie de la COVID-19.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

osimertinib

( OH sim ER ti nib )
Funding:
Exceptional Access Program
  • osimertinib - For the treatment of locally advanced (not amenable to curative therapies) or metastatic non-small cell lung cancer (NSCLC) according to clinical criteria
Other Name(s): Tagrisso®
Appearance: tablet in various strengths, shapes and colours

Patient Info Sheet

Jun 2020

What it is used for

  • For treating a certain type of non-small cell lung cancer that:
    • cannot be removed by surgery
    • cannot be cured by chemotherapy or radiation
    • has spread to other parts of the body.


You might also be interested in